Quarterly report pursuant to Section 13 or 15(d)

Business and Organization (Details)

v3.4.0.3
Business and Organization (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended
Aug. 20, 2015
USD ($)
May. 05, 2015
USD ($)
$ / shares
shares
Aug. 31, 2015
USD ($)
$ / shares
shares
May. 31, 2015
USD ($)
$ / shares
shares
Mar. 31, 2016
employee
Business Acquisition [Line Items]          
Number of sales employees | employee         420
Bio Reference          
Business Acquisition [Line Items]          
Consideration transferred     $ 950,148    
Common stock value $ 2,259   $ 2,259    
Cash paid at closing date $ 950,148        
EirGen          
Business Acquisition [Line Items]          
Consideration transferred   $ 133,800   $ 133,800  
Common stock value   33,600   33,600  
Cash paid at closing date   $ 100,200   $ 100,200  
Common Stock          
Business Acquisition [Line Items]          
Stock price per share | $ / shares   $ 13.88 $ 12.38 $ 13.88  
Common Stock | Bio Reference          
Business Acquisition [Line Items]          
Common stock received | shares     76,566,147    
Acquired entity share price | $ / shares     $ 34.05    
Common Stock | EirGen          
Business Acquisition [Line Items]          
Common stock received | shares   2,420,487   2,420,487